semaglutide cardiovascular outcomes study 2025 news and by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial semaglutide cardiovascular outcomes news 2025

Due to the prevalence of musculoskeletal conditions in patients with diabetes and obesity, physical therapists can play a crucial role in the comprehensive care of patients on GLP-1 agonist therapy

However, in the latest guideline of American Diabetes Association (ADA 2023), the effect on major cardiovascular episodes (MACE) of metformin remains potential [9]

Who Can Receive Weight Loss Medications Weight loss medications are typically prescribed for adults with a BMI of 30 or higher, or a BMI of 27 or higher in conjunction with conditions like type 2 diabetes or high blood pressure

As an acne prevention treatment, it is not only going to help with your acne problem, it will also protect your skin from future breakouts

When GLP-1, GLP-2, or VIP were added to these neuronmast-cell co-cultures, researchers observed complete reversal of neuronal death, with all three peptides enhancing neuronal survival in a concentration-dependent manner